Asiaticoside Antagonizes Proliferation and Chemotherapeutic Drug Resistance in Hepatocellular Carcinoma (HCC) Cells

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most prevalent malignant tumor in China after lung cancer, gastric cancer, esophageal cancer, and breast cancer, and has a high mortality rate. Though there are a series of therapeutic strategies is now available for HCC in clinical practice, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ying, Wen, Jun, Wang, Jing, Wang, Chunyan, Zhang, Yan, Zhao, Lili, Li, Jia, Feng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480090/
https://www.ncbi.nlm.nih.gov/pubmed/32862187
http://dx.doi.org/10.12659/MSM.924435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480090/
https://www.ncbi.nlm.nih.gov/pubmed/32862187
http://dx.doi.org/10.12659/MSM.924435

Ejemplares similares